A systematic review to identify and collate factors influencing patient journeys through clinical trials.

Clinical trials (epidemiology)<Epidemiology<NON-CLINICAL effectiveness of care<Evidence based practice<CLINICAL

Journal

JRSM open
ISSN: 2054-2704
Titre abrégé: JRSM Open
Pays: England
ID NLM: 101625786

Informations de publication

Date de publication:
Jun 2023
Historique:
pubmed: 16 6 2023
medline: 16 6 2023
entrez: 16 6 2023
Statut: epublish

Résumé

Patient-centred trial design and delivery; improves recruitment and retention; increases participant satisfaction; encourages participation by a more representative cohort; and allows researchers to better meet participants' needs. Research in this area mostly focusses on narrow facets of trial participation. We aimed to systematically identify the breadth of patient-centred factors influencing participation and engagement in trials, and collate them into a framework. Through this we hoped to assist researchers to identify factors that could improve patient-centred trial design and delivery. Robust qualitative and mixed methods systematic reviews are becoming increasingly common in health research. The protocol for this review was prospectively registered on PROSPERO, CRD42020184886. We used the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research Type) framework as a standardised systematic search strategy tool. 3 databases were searched as well as references checking, and thematic synthesis was conducted. Screening agreement was performed and code and theme checking were conducted by 2 independent researchers. Data were drawn from 285 peer-reviewed articles. 300 discrete factors were identified, and sorted into 13 themes and subthemes. The full catalogue of factors is included in the Supplementary Material. A summary framework is included in the body of the article. This paper focusses on outlining common ground that themes share, highlighting critical features, and exploring interesting points from the data. Through this, we hope researchers from multiple specialities may be better able to meet patients' needs, protect patients' psychosocial wellbeing, and optimise trial recruitment and retention, with direct positive impact on research time and cost efficiency.

Identifiants

pubmed: 37325779
doi: 10.1177/20542704231166621
pii: 10.1177_20542704231166621
pmc: PMC10262634
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20542704231166621

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Rebecca Dobra (R)

National Heart and Lung Institute, Imperial College London, London, UK.
Royal Brompton Hospital, London, UK.

Gemma Wilson (G)

National Heart and Lung Institute, Imperial College London, London, UK.

Jessie Matthews (J)

National Heart and Lung Institute, Imperial College London, London, UK.

Marco Boeri (M)

RTI Solutions, Belfast, UK.

Stuart Elborn (S)

Queen's University, Belfast, UK.

Frank Kee (F)

Queen's University, Belfast, UK.

Jane C Davies (JC)

National Heart and Lung Institute, Imperial College London, London, UK.
Royal Brompton Hospital, London, UK.

Susan Madge (S)

Royal Brompton Hospital, London, UK.

Classifications MeSH